Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
N5-(4,5-Dihydro-5-oxo-1H-imidazol-2-yl)-L-ornithine is an advanced glycation end-products that can be used to predict loss of renal function in American Indians with type 2 diabetes.